Literature DB >> 12855835

Very early risk of stroke after a first transient ischemic attack.

J K Lovett1, M S Dennis, P A G Sandercock, J Bamford, C P Warlow, P M Rothwell.   

Abstract

BACKGROUND AND
PURPOSE: The commonly quoted early risks of stroke after a first transient ischemic attack (TIA)-1% to 2% at 7 days and 2% to 4% at 1 month-are likely to be underestimates because of the delay before inclusion into previous studies and the exclusion of patients who had a stroke during this time. Therefore, it is uncertain how urgently TIA patients should be assessed. We used data from the Oxford Community Stroke Project (OCSP) to estimate the very early stroke risk after a TIA and investigated the potential effects of the delays before specialist assessment.
METHODS: All OCSP patients who had a first-ever definite TIA during the study period (n=209) were included. Three analyses were used to estimate the early stroke risk after a first TIA starting from 3 different dates: assessment by a neurologist, referral to the TIA service, and onset of first TIA.
RESULTS: The stroke risk from assessment by a neurologist was 1.9% [95% confidence interval (CI), 0.1 to 3.8] at 7 days and 4.4% (95% CI, 1.6 to 7.2) at 30 days. The 7- and 30-day stroke risks from referral were 2.4% (95% CI, 0.3 to 4.5) and 4.9% (95% CI, 1.9 to 7.8), respectively, and from onset of first-ever TIA were 8.6% (95% CI, 4.8 to 12.4) and 12.0% (95% CI, 7.6 to 16.4), respectively.
CONCLUSIONS: The early risk of stroke from date of first-ever TIA is likely to be higher than commonly quoted. Public education about the symptoms of TIA is needed so that medical attention is sought more urgently and stroke prevention strategies are implemented sooner.

Entities:  

Mesh:

Year:  2003        PMID: 12855835     DOI: 10.1161/01.STR.0000080935.01264.91

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  58 in total

1.  Early risk of stroke after transient ischemic attack: back to the future.

Authors:  Piero Verro
Journal:  CMAJ       Date:  2004-03-30       Impact factor: 8.262

2.  Risk of wound hematoma at carotid endarterectomy under dual antiplatelet therapy.

Authors:  Andreas Oldag; Stephan Schreiber; Stefanie Schreiber; Hans-Jochen Heinze; Frank Meyer; Mathias Weber; Zuhir Halloul; Michael Goertler
Journal:  Langenbecks Arch Surg       Date:  2012-06-08       Impact factor: 3.445

Review 3.  Evolving concepts regarding transient ischemic attacks.

Authors:  Bernardo Liberato; Shyam Prabhakaran; Ralph L Sacco
Journal:  Curr Atheroscler Rep       Date:  2005-07       Impact factor: 5.113

4.  The use of neurovascular imaging for triaging TIA and minor stroke: implications for therapy.

Authors:  Andrew M Demchuk
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

5.  Can the ABCD Score be dichotomised to identify high-risk patients with transient ischaemic attack in the emergency department?

Authors:  Janet E Bray; Kelly Coughlan; Christopher Bladin
Journal:  Emerg Med J       Date:  2007-02       Impact factor: 2.740

Review 6.  Management of symptomatic carotid disease in 2014.

Authors:  Jason Litsky; Erik Stilp; Roland Njoh; Carlos Mena-Hurtado
Journal:  Curr Cardiol Rep       Date:  2014-03       Impact factor: 2.931

7.  The ABCD(2) Score is Highly Predictive of Stroke in Minor Ischemic Stroke Patients.

Authors:  Kavian Ghandehari; Fahimeh Ahmadi; Saeed Ebrahimzadeh; Keyvan Shariatinezhad; Kosar Ghandehari
Journal:  Transl Stroke Res       Date:  2012-05-22       Impact factor: 6.829

Review 8.  Current treatments in neurology: stroke.

Authors:  Hugh S Markus
Journal:  J Neurol       Date:  2005-03-07       Impact factor: 4.849

Review 9.  Management of carotid artery stenosis. Update for family physicians.

Authors:  George Louridas; Asad Junaid
Journal:  Can Fam Physician       Date:  2005-07       Impact factor: 3.275

10.  Prognostic value of the ABCD2 score beyond short-term follow-up after transient ischemic attack (TIA)--a cohort study.

Authors:  Katrin Holzer; Regina Feurer; Suwad Sadikovic; Lorena Esposito; Angelina Bockelbrink; Dirk Sander; Bernhard Hemmer; Holger Poppert
Journal:  BMC Neurol       Date:  2010-06-21       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.